Pharma & Healthcare
Global Mebendazole Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 25, 25
- ID: 331990
- Pages: 131
- Figures: 123
- Views: 2
In 2024, the global market size of Mebendazole was estimated to be worth US$ 131 million and is forecast to reach approximately US$ 191 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for =2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mebendazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mebendazole.
The Mebendazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mebendazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mebendazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Segment by Type
Tablet
Oral Suspension
Segment by Application
Below 2 Years Old
Above 2 Years Old
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Mebendazole in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Mebendazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mebendazole sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for =2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mebendazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mebendazole.
The Mebendazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mebendazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mebendazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Segment by Type
Tablet
Oral Suspension
Segment by Application
Below 2 Years Old
Above 2 Years Old
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Mebendazole in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Mebendazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mebendazole sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Mebendazole Product Introduction
1.2 Market by Type
1.2.1 Global Mebendazole Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Tablet
1.2.3 Oral Suspension
1.3 Market by Application
1.3.1 Global Mebendazole Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Below 2 Years Old
1.3.3 Above 2 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mebendazole Market Size Estimates and Forecasts
2.1.1 Global Mebendazole Revenue 2020-2031
2.1.2 Global Mebendazole Sales 2020-2031
2.2 Mebendazole Market Size by Region: 2024 Versus 2031
2.3 Mebendazole Sales by Region (2020-2031)
2.3.1 Global Mebendazole Sales by Region: 2020-2025
2.3.2 Global Mebendazole Sales Forecast by Region (2026-2031)
2.3.3 Global Mebendazole Sales Market Share by Region (2020-2031)
2.4 Mebendazole Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Mebendazole Revenue by Region: 2020-2025
2.4.2 Global Mebendazole Revenue Forecast by Region (2026-2031)
2.4.3 Global Mebendazole Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Mebendazole Sales by Type (2020-2031)
3.1.1.1 Global Mebendazole Sales Volume by Type (2020-2031)
3.1.1.2 Global Mebendazole Sales Market Share by Type (2020-2031)
3.1.2 Global Mebendazole Revenue by Type (2020-2031)
3.1.2.1 Global Mebendazole Revenue by Type (2020-2031)
3.1.2.2 Global Mebendazole Revenue Market Share by Type (2020-2031)
3.1.3 Mebendazole Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Mebendazole Sales by Application (2020-2031)
3.2.1.1 Global Mebendazole Sales Volume by Application (2020-2031)
3.2.1.2 Global Mebendazole Sales Market Share by Application (2020-2031)
3.2.2 Global Mebendazole Revenue by Application (2020-2031)
3.2.2.1 Global Mebendazole Revenue by Application (2020-2031)
3.2.2.2 Global Mebendazole Revenue Market Share by Application (2020-2031)
3.2.3 Mebendazole Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Tablet of Mebendazole Revenue Market Share by Application
3.3.2 Oral Suspension of Mebendazole Revenue Market Share by Application
4 Global Mebendazole by Manufacturers
4.1 Global Top Mebendazole Manufacturers by Sales (2020-2025)
4.1.1 Global Mebendazole Sales by Manufacturer (2020-2025)
4.1.2 Global Mebendazole Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Mebendazole Manufacturers by Revenue (2020-2025)
4.2.1 Global Mebendazole Revenue by Manufacturer (2020-2025)
4.2.2 Global Mebendazole Revenue Share by Manufacturer (2020-2025)
4.3 Global Mebendazole Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Mebendazole Manufacturers Covered: Ranking by Revenue
4.4.2 Global Mebendazole Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Mebendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Mebendazole Manufacturing Base Distribution, Product Type
4.5.1 Mebendazole Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Mebendazole Market
4.5.3 Manufacturers Mebendazole Product Type and Application
4.5.4 Tablet Market Sales of Mebendazole by Manufacturer
4.5.5 Oral Suspension Market Sales of Mebendazole by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Company Information
5.1.2 Johnson & Johnson Description, Business Overview
5.1.3 Johnson & Johnson Mebendazole Products Offered
5.1.4 Johnson & Johnson Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Johnson & Johnson Mebendazole Sales by Product in 2024
5.1.6 Johnson & Johnson Mebendazole Sales by Application in 2024
5.1.7 Johnson & Johnson Mebendazole Sales by Geographic Area in 2024
5.1.8 Johnson & Johnson Recent Developments
5.2 Amneal Pharmaceuticals
5.2.1 Amneal Pharmaceuticals Company Information
5.2.2 Amneal Pharmaceuticals Description, Business Overview
5.2.3 Amneal Pharmaceuticals Mebendazole Products Offered
5.2.4 Amneal Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Amneal Pharmaceuticals Mebendazole Sales by Product in 2024
5.2.6 Amneal Pharmaceuticals Mebendazole Sales by Application in 2024
5.2.7 Amneal Pharmaceuticals Mebendazole Sales by Geographic Area in 2024
5.2.8 Amneal Pharmaceuticals Recent Developments
5.3 Cadila Pharmaceuticals
5.3.1 Cadila Pharmaceuticals Company Information
5.3.2 Cadila Pharmaceuticals Description, Business Overview
5.3.3 Cadila Pharmaceuticals Mebendazole Products Offered
5.3.4 Cadila Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Cadila Pharmaceuticals Mebendazole Sales by Product in 2024
5.3.6 Cadila Pharmaceuticals Mebendazole Sales by Application in 2024
5.3.7 Cadila Pharmaceuticals Mebendazole Sales by Geographic Area in 2024
5.3.8 Cadila Pharmaceuticals Recent Developments
5.4 Eipico
5.4.1 Eipico Company Information
5.4.2 Eipico Description, Business Overview
5.4.3 Eipico Mebendazole Products Offered
5.4.4 Eipico Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Eipico Mebendazole Sales by Product in 2024
5.4.6 Eipico Mebendazole Sales by Application in 2024
5.4.7 Eipico Mebendazole Sales by Geographic Area in 2024
5.4.8 Eipico Recent Developments
5.5 Esteve Pharmaceuticals
5.5.1 Esteve Pharmaceuticals Company Information
5.5.2 Esteve Pharmaceuticals Description, Business Overview
5.5.3 Esteve Pharmaceuticals Mebendazole Products Offered
5.5.4 Esteve Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Esteve Pharmaceuticals Mebendazole Sales by Product in 2024
5.5.6 Esteve Pharmaceuticals Mebendazole Sales by Application in 2024
5.5.7 Esteve Pharmaceuticals Mebendazole Sales by Geographic Area in 2024
5.5.8 Esteve Pharmaceuticals Recent Developments
5.6 Tenry
5.6.1 Tenry Company Information
5.6.2 Tenry Description, Business Overview
5.6.3 Tenry Mebendazole Products Offered
5.6.4 Tenry Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Tenry Mebendazole Sales by Product in 2024
5.6.6 Tenry Mebendazole Sales by Application in 2024
5.6.7 Tenry Mebendazole Sales by Geographic Area in 2024
5.6.8 Tenry Recent Developments
6 North America
6.1 North America Mebendazole Market Size YoY Growth 2020-2031
6.2 North America Mebendazole Market Facts & Figures by Country
6.2.1 North America Mebendazole Sales by Country (2020-2031)
6.2.2 North America Mebendazole Revenue by Country (2020-2031)
6.3 North America Mebendazole Sales by Type (2020-2025)
6.4 North America Mebendazole Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Mebendazole Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Mebendazole Market Facts & Figures by Region
7.2.1 Asia-Pacific Mebendazole Sales by Region (2020-2031)
7.2.2 Asia-Pacific Mebendazole Revenue by Region (2020-2031)
7.3 Asia-Pacific Mebendazole Sales by Type (2020-2025)
7.4 Asia-Pacific Mebendazole Sales by Application (2020-2025)
8 Europe
8.1 Europe Mebendazole Market Size YoY Growth 2020-2031
8.2 Europe Mebendazole Market Facts & Figures by Country
8.2.1 Europe Mebendazole Sales by Country (2020-2031)
8.2.2 Europe Mebendazole Revenue by Country (2020-2031)
8.3 Europe Mebendazole Sales by Type (2020-2025)
8.4 Europe Mebendazole Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Mebendazole Market Size YoY Growth 2020-2031
9.2 Latin America Mebendazole Market Facts & Figures by Country
9.2.1 Latin America Mebendazole Sales by Country (2020-2031)
9.2.2 Latin America Mebendazole Revenue by Country (2020-2031)
9.3 Latin America Mebendazole Sales by Type (2020-2025)
9.4 Latin America Mebendazole Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Mebendazole Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Mebendazole Market Facts & Figures by Country
10.2.1 Middle East and Africa Mebendazole Sales by Country (2020-2031)
10.2.2 Middle East and Africa Mebendazole Revenue by Country (2020-2031)
10.3 Middle East and Africa Mebendazole Sales by Type (2020-2025)
10.4 Middle East and Africa Mebendazole Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Mebendazole Supply Chain Analysis
11.2 Mebendazole Key Raw Materials and Upstream Suppliers
11.3 Mebendazole Clients Analysis
11.4 Mebendazole Sales Channel and Sales Model Analysis
11.4.1 Mebendazole Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Mebendazole Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Mebendazole Distributors
12 Mebendazole Market Dynamics
12.1 Mebendazole Industry Trends
12.2 Mebendazole Market Drivers
12.3 Mebendazole Market Challenges
12.4 Mebendazole Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Mebendazole Product Introduction
1.2 Market by Type
1.2.1 Global Mebendazole Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Tablet
1.2.3 Oral Suspension
1.3 Market by Application
1.3.1 Global Mebendazole Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Below 2 Years Old
1.3.3 Above 2 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mebendazole Market Size Estimates and Forecasts
2.1.1 Global Mebendazole Revenue 2020-2031
2.1.2 Global Mebendazole Sales 2020-2031
2.2 Mebendazole Market Size by Region: 2024 Versus 2031
2.3 Mebendazole Sales by Region (2020-2031)
2.3.1 Global Mebendazole Sales by Region: 2020-2025
2.3.2 Global Mebendazole Sales Forecast by Region (2026-2031)
2.3.3 Global Mebendazole Sales Market Share by Region (2020-2031)
2.4 Mebendazole Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Mebendazole Revenue by Region: 2020-2025
2.4.2 Global Mebendazole Revenue Forecast by Region (2026-2031)
2.4.3 Global Mebendazole Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Mebendazole Sales by Type (2020-2031)
3.1.1.1 Global Mebendazole Sales Volume by Type (2020-2031)
3.1.1.2 Global Mebendazole Sales Market Share by Type (2020-2031)
3.1.2 Global Mebendazole Revenue by Type (2020-2031)
3.1.2.1 Global Mebendazole Revenue by Type (2020-2031)
3.1.2.2 Global Mebendazole Revenue Market Share by Type (2020-2031)
3.1.3 Mebendazole Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Mebendazole Sales by Application (2020-2031)
3.2.1.1 Global Mebendazole Sales Volume by Application (2020-2031)
3.2.1.2 Global Mebendazole Sales Market Share by Application (2020-2031)
3.2.2 Global Mebendazole Revenue by Application (2020-2031)
3.2.2.1 Global Mebendazole Revenue by Application (2020-2031)
3.2.2.2 Global Mebendazole Revenue Market Share by Application (2020-2031)
3.2.3 Mebendazole Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Tablet of Mebendazole Revenue Market Share by Application
3.3.2 Oral Suspension of Mebendazole Revenue Market Share by Application
4 Global Mebendazole by Manufacturers
4.1 Global Top Mebendazole Manufacturers by Sales (2020-2025)
4.1.1 Global Mebendazole Sales by Manufacturer (2020-2025)
4.1.2 Global Mebendazole Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Mebendazole Manufacturers by Revenue (2020-2025)
4.2.1 Global Mebendazole Revenue by Manufacturer (2020-2025)
4.2.2 Global Mebendazole Revenue Share by Manufacturer (2020-2025)
4.3 Global Mebendazole Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Mebendazole Manufacturers Covered: Ranking by Revenue
4.4.2 Global Mebendazole Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Mebendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Mebendazole Manufacturing Base Distribution, Product Type
4.5.1 Mebendazole Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Mebendazole Market
4.5.3 Manufacturers Mebendazole Product Type and Application
4.5.4 Tablet Market Sales of Mebendazole by Manufacturer
4.5.5 Oral Suspension Market Sales of Mebendazole by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Company Information
5.1.2 Johnson & Johnson Description, Business Overview
5.1.3 Johnson & Johnson Mebendazole Products Offered
5.1.4 Johnson & Johnson Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Johnson & Johnson Mebendazole Sales by Product in 2024
5.1.6 Johnson & Johnson Mebendazole Sales by Application in 2024
5.1.7 Johnson & Johnson Mebendazole Sales by Geographic Area in 2024
5.1.8 Johnson & Johnson Recent Developments
5.2 Amneal Pharmaceuticals
5.2.1 Amneal Pharmaceuticals Company Information
5.2.2 Amneal Pharmaceuticals Description, Business Overview
5.2.3 Amneal Pharmaceuticals Mebendazole Products Offered
5.2.4 Amneal Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Amneal Pharmaceuticals Mebendazole Sales by Product in 2024
5.2.6 Amneal Pharmaceuticals Mebendazole Sales by Application in 2024
5.2.7 Amneal Pharmaceuticals Mebendazole Sales by Geographic Area in 2024
5.2.8 Amneal Pharmaceuticals Recent Developments
5.3 Cadila Pharmaceuticals
5.3.1 Cadila Pharmaceuticals Company Information
5.3.2 Cadila Pharmaceuticals Description, Business Overview
5.3.3 Cadila Pharmaceuticals Mebendazole Products Offered
5.3.4 Cadila Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Cadila Pharmaceuticals Mebendazole Sales by Product in 2024
5.3.6 Cadila Pharmaceuticals Mebendazole Sales by Application in 2024
5.3.7 Cadila Pharmaceuticals Mebendazole Sales by Geographic Area in 2024
5.3.8 Cadila Pharmaceuticals Recent Developments
5.4 Eipico
5.4.1 Eipico Company Information
5.4.2 Eipico Description, Business Overview
5.4.3 Eipico Mebendazole Products Offered
5.4.4 Eipico Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Eipico Mebendazole Sales by Product in 2024
5.4.6 Eipico Mebendazole Sales by Application in 2024
5.4.7 Eipico Mebendazole Sales by Geographic Area in 2024
5.4.8 Eipico Recent Developments
5.5 Esteve Pharmaceuticals
5.5.1 Esteve Pharmaceuticals Company Information
5.5.2 Esteve Pharmaceuticals Description, Business Overview
5.5.3 Esteve Pharmaceuticals Mebendazole Products Offered
5.5.4 Esteve Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Esteve Pharmaceuticals Mebendazole Sales by Product in 2024
5.5.6 Esteve Pharmaceuticals Mebendazole Sales by Application in 2024
5.5.7 Esteve Pharmaceuticals Mebendazole Sales by Geographic Area in 2024
5.5.8 Esteve Pharmaceuticals Recent Developments
5.6 Tenry
5.6.1 Tenry Company Information
5.6.2 Tenry Description, Business Overview
5.6.3 Tenry Mebendazole Products Offered
5.6.4 Tenry Mebendazole Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Tenry Mebendazole Sales by Product in 2024
5.6.6 Tenry Mebendazole Sales by Application in 2024
5.6.7 Tenry Mebendazole Sales by Geographic Area in 2024
5.6.8 Tenry Recent Developments
6 North America
6.1 North America Mebendazole Market Size YoY Growth 2020-2031
6.2 North America Mebendazole Market Facts & Figures by Country
6.2.1 North America Mebendazole Sales by Country (2020-2031)
6.2.2 North America Mebendazole Revenue by Country (2020-2031)
6.3 North America Mebendazole Sales by Type (2020-2025)
6.4 North America Mebendazole Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Mebendazole Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Mebendazole Market Facts & Figures by Region
7.2.1 Asia-Pacific Mebendazole Sales by Region (2020-2031)
7.2.2 Asia-Pacific Mebendazole Revenue by Region (2020-2031)
7.3 Asia-Pacific Mebendazole Sales by Type (2020-2025)
7.4 Asia-Pacific Mebendazole Sales by Application (2020-2025)
8 Europe
8.1 Europe Mebendazole Market Size YoY Growth 2020-2031
8.2 Europe Mebendazole Market Facts & Figures by Country
8.2.1 Europe Mebendazole Sales by Country (2020-2031)
8.2.2 Europe Mebendazole Revenue by Country (2020-2031)
8.3 Europe Mebendazole Sales by Type (2020-2025)
8.4 Europe Mebendazole Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Mebendazole Market Size YoY Growth 2020-2031
9.2 Latin America Mebendazole Market Facts & Figures by Country
9.2.1 Latin America Mebendazole Sales by Country (2020-2031)
9.2.2 Latin America Mebendazole Revenue by Country (2020-2031)
9.3 Latin America Mebendazole Sales by Type (2020-2025)
9.4 Latin America Mebendazole Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Mebendazole Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Mebendazole Market Facts & Figures by Country
10.2.1 Middle East and Africa Mebendazole Sales by Country (2020-2031)
10.2.2 Middle East and Africa Mebendazole Revenue by Country (2020-2031)
10.3 Middle East and Africa Mebendazole Sales by Type (2020-2025)
10.4 Middle East and Africa Mebendazole Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Mebendazole Supply Chain Analysis
11.2 Mebendazole Key Raw Materials and Upstream Suppliers
11.3 Mebendazole Clients Analysis
11.4 Mebendazole Sales Channel and Sales Model Analysis
11.4.1 Mebendazole Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Mebendazole Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Mebendazole Distributors
12 Mebendazole Market Dynamics
12.1 Mebendazole Industry Trends
12.2 Mebendazole Market Drivers
12.3 Mebendazole Market Challenges
12.4 Mebendazole Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Mebendazole Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Mebendazole Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Mebendazole Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Mebendazole Sales by Region (2020-2025) & (K Units)
Table 5. Global Mebendazole Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Mebendazole Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Mebendazole Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Mebendazole Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Mebendazole Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Mebendazole Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Mebendazole Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Mebendazole Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Mebendazole Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Mebendazole Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Mebendazole Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Mebendazole Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Mebendazole Sales Share by Manufacturer (2020-2025)
Table 18. Mebendazole Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Mebendazole Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Mebendazole Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Mebendazole Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Mebendazole Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Mebendazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mebendazole as of 2024)
Table 24. Mebendazole Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Mebendazole Market
Table 26. Manufacturers Mebendazole Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Johnson & Johnson Company Information
Table 29. Johnson & Johnson Description and Business Overview
Table 30. Johnson & Johnson Mebendazole Product
Table 31. Johnson & Johnson Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Johnson & Johnson Sales Proportion of Mebendazole by Product in 2024
Table 33. Johnson & Johnson Sales Proportion of Mebendazole by Application in 2024
Table 34. Johnson & Johnson Sales Proportion of Mebendazole by Geographic Area in 2024
Table 35. Johnson & Johnson Recent Developments
Table 36. Amneal Pharmaceuticals Company Information
Table 37. Amneal Pharmaceuticals Description and Business Overview
Table 38. Amneal Pharmaceuticals Mebendazole Product
Table 39. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Amneal Pharmaceuticals Sales Proportion of Mebendazole by Product in 2024
Table 41. Amneal Pharmaceuticals Sales Proportion of Mebendazole by Application in 2024
Table 42. Amneal Pharmaceuticals Sales Proportion of Mebendazole by Geographic Area in 2024
Table 43. Amneal Pharmaceuticals Recent Developments
Table 44. Cadila Pharmaceuticals Company Information
Table 45. Cadila Pharmaceuticals Description and Business Overview
Table 46. Cadila Pharmaceuticals Mebendazole Product
Table 47. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Cadila Pharmaceuticals Sales Proportion of Mebendazole by Product in 2024
Table 49. Cadila Pharmaceuticals Sales Proportion of Mebendazole by Application in 2024
Table 50. Cadila Pharmaceuticals Sales Proportion of Mebendazole by Geographic Area in 2024
Table 51. Cadila Pharmaceuticals Recent Developments
Table 52. Eipico Company Information
Table 53. Eipico Description and Business Overview
Table 54. Eipico Mebendazole Product
Table 55. Eipico Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Eipico Sales Proportion of Mebendazole by Product in 2024
Table 57. Eipico Sales Proportion of Mebendazole by Application in 2024
Table 58. Eipico Sales Proportion of Mebendazole by Geographic Area in 2024
Table 59. Eipico Recent Developments
Table 60. Esteve Pharmaceuticals Company Information
Table 61. Esteve Pharmaceuticals Description and Business Overview
Table 62. Esteve Pharmaceuticals Mebendazole Product
Table 63. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Esteve Pharmaceuticals Sales Proportion of Mebendazole by Product in 2024
Table 65. Esteve Pharmaceuticals Sales Proportion of Mebendazole by Application in 2024
Table 66. Esteve Pharmaceuticals Sales Proportion of Mebendazole by Geographic Area in 2024
Table 67. Esteve Pharmaceuticals Recent Developments
Table 68. Tenry Company Information
Table 69. Tenry Description and Business Overview
Table 70. Tenry Mebendazole Product
Table 71. Tenry Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Tenry Sales Proportion of Mebendazole by Product in 2024
Table 73. Tenry Sales Proportion of Mebendazole by Application in 2024
Table 74. Tenry Sales Proportion of Mebendazole by Geographic Area in 2024
Table 75. Tenry Recent Developments
Table 76. North America Mebendazole Sales by Country (2020-2025) & (K Units)
Table 77. North America Mebendazole Sales by Country (2026-2031) & (K Units)
Table 78. North America Mebendazole Revenue by Country (2020-2025) & (US$ Million)
Table 79. North America Mebendazole Revenue by Country (2026-2031) & (US$ Million)
Table 80. North America Mebendazole Sales by Type (2020-2025) & (K Units)
Table 81. North America Mebendazole Sales by Application (2020-2025) & (K Units)
Table 82. Asia-Pacific Mebendazole Sales by Region (2020-2025) & (K Units)
Table 83. Asia-Pacific Mebendazole Sales by Region (2026-2031) & (K Units)
Table 84. Asia-Pacific Mebendazole Revenue by Region (2020-2025) & (US$ Million)
Table 85. Asia-Pacific Mebendazole Revenue by Region (2026-2031) & (US$ Million)
Table 86. Asia-Pacific Mebendazole Sales by Type (2020-2025) & (K Units)
Table 87. Asia-Pacific Mebendazole Sales by Application (2020-2025) & (K Units)
Table 88. Europe Mebendazole Sales by Country (2020-2025) & (K Units)
Table 89. Europe Mebendazole Sales by Country (2026-2031) & (K Units)
Table 90. Europe Mebendazole Revenue by Country (2020-2025) & (US$ Million)
Table 91. Europe Mebendazole Revenue by Country (2026-2031) & (US$ Million)
Table 92. Europe Mebendazole Sales by Type (2020-2025) & (K Units)
Table 93. Europe Mebendazole Sales by Application (2020-2025) & (K Units)
Table 94. Latin America Mebendazole Sales by Country (2020-2025) & (K Units)
Table 95. Latin America Mebendazole Sales by Country (2026-2031) & (K Units)
Table 96. Latin America Mebendazole Revenue by Country (2020-2025) & (US$ Million)
Table 97. Latin America Mebendazole Revenue by Country (2026-2031) & (US$ Million)
Table 98. Latin America Mebendazole Sales by Type (2020-2025) & (K Units)
Table 99. Latin America Mebendazole Sales by Application (2020-2025) & (K Units)
Table 100. Middle East and Africa Mebendazole Sales by Country (2020-2025) & (K Units)
Table 101. Middle East and Africa Mebendazole Sales by Country (2026-2031) & (K Units)
Table 102. Middle East and Africa Mebendazole Revenue by Country (2020-2025) & (US$ Million)
Table 103. Middle East and Africa Mebendazole Revenue by Country (2026-2031) & (US$ Million)
Table 104. Middle East and Africa Mebendazole Sales by Type (2020-2025) & (K Units)
Table 105. Middle East and Africa Mebendazole Sales by Application (2020-2025) & (K Units)
Table 106. Mebendazole Key Raw Materials, Industry Status and Trend
Table 107. Mebendazole Key Raw Materials and Upstream Suppliers
Table 108. Mebendazole Clients Status and Trend
Table 109. Mebendazole Typical Clients
Table 110. Mebendazole Distributors
Table 111. Mebendazole Market Trends
Table 112. Mebendazole Market Drivers
Table 113. Mebendazole Market Challenges
Table 114. Mebendazole Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Mebendazole Product Picture
Figure 2. Global Mebendazole Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Mebendazole Sales Market Share by Type in 2024 & 2031
Figure 4. Tablet Product Picture
Figure 5. Oral Suspension Product Picture
Figure 6. Global Mebendazole Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Mebendazole Sales Market Share by Application in 2024 & 2031
Figure 8. Below 2 Years Old
Figure 9. Above 2 Years Old
Figure 10. Mebendazole Report Years Considered
Figure 11. Global Mebendazole Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Mebendazole Market Size 2020-2031 (US$ Million)
Figure 13. Global Mebendazole Sales 2020-2031 (K Units)
Figure 14. Global Mebendazole Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Mebendazole Revenue Market Share by Region (2020-2031)
Figure 16. Global Mebendazole Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Mebendazole Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Mebendazole Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 19. Global Mebendazole Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Mebendazole Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Mebendazole Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 22. Tablet of Mebendazole Revenue Market Share by Application, 2024 VS 2031
Figure 23. Oral Suspension of Mebendazole Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Mebendazole Sales Share by Manufacturer in 2024
Figure 25. Mebendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Tablet Market Sales Proportion by Manufacturer in 2024
Figure 27. Oral Suspension Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Mebendazole Revenue 2020-2031 (US$ Million)
Figure 29. North America Mebendazole Sales Market Share by Type (2020-2025)
Figure 30. North America Mebendazole Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Mebendazole Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Mebendazole Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Mebendazole Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Mebendazole Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Mebendazole Sales Market Share by Application (2020-2025)
Figure 36. Europe Mebendazole Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Mebendazole Sales Market Share by Country (2020-2031)
Figure 38. Europe Mebendazole Revenue Market Share by Country (2020-2031)
Figure 39. Europe Mebendazole Sales Market Share by Type (2020-2025)
Figure 40. Europe Mebendazole Sales Market Share by Application (2020-2025)
Figure 41. Latin America Mebendazole Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Mebendazole Sales Market Share by Country (2020-2031)
Figure 43. Latin America Mebendazole Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Mebendazole Sales Market Share by Type (2020-2025)
Figure 45. Latin America Mebendazole Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Mebendazole Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Mebendazole Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Mebendazole Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Mebendazole Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Mebendazole Sales Market Share by Application (2020-2025)
Figure 51. Mebendazole Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Mebendazole Raw Materials by Region in 2024
Figure 53. Mebendazole Distribution Channels
Figure 54. Global Mebendazole Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Mebendazole Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Mebendazole Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Mebendazole Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Mebendazole Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Mebendazole Sales by Region (2020-2025) & (K Units)
Table 5. Global Mebendazole Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Mebendazole Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Mebendazole Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Mebendazole Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Mebendazole Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Mebendazole Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Mebendazole Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Mebendazole Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Mebendazole Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Mebendazole Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Mebendazole Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Mebendazole Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Mebendazole Sales Share by Manufacturer (2020-2025)
Table 18. Mebendazole Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Mebendazole Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Mebendazole Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Mebendazole Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Mebendazole Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Mebendazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mebendazole as of 2024)
Table 24. Mebendazole Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Mebendazole Market
Table 26. Manufacturers Mebendazole Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Johnson & Johnson Company Information
Table 29. Johnson & Johnson Description and Business Overview
Table 30. Johnson & Johnson Mebendazole Product
Table 31. Johnson & Johnson Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Johnson & Johnson Sales Proportion of Mebendazole by Product in 2024
Table 33. Johnson & Johnson Sales Proportion of Mebendazole by Application in 2024
Table 34. Johnson & Johnson Sales Proportion of Mebendazole by Geographic Area in 2024
Table 35. Johnson & Johnson Recent Developments
Table 36. Amneal Pharmaceuticals Company Information
Table 37. Amneal Pharmaceuticals Description and Business Overview
Table 38. Amneal Pharmaceuticals Mebendazole Product
Table 39. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Amneal Pharmaceuticals Sales Proportion of Mebendazole by Product in 2024
Table 41. Amneal Pharmaceuticals Sales Proportion of Mebendazole by Application in 2024
Table 42. Amneal Pharmaceuticals Sales Proportion of Mebendazole by Geographic Area in 2024
Table 43. Amneal Pharmaceuticals Recent Developments
Table 44. Cadila Pharmaceuticals Company Information
Table 45. Cadila Pharmaceuticals Description and Business Overview
Table 46. Cadila Pharmaceuticals Mebendazole Product
Table 47. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Cadila Pharmaceuticals Sales Proportion of Mebendazole by Product in 2024
Table 49. Cadila Pharmaceuticals Sales Proportion of Mebendazole by Application in 2024
Table 50. Cadila Pharmaceuticals Sales Proportion of Mebendazole by Geographic Area in 2024
Table 51. Cadila Pharmaceuticals Recent Developments
Table 52. Eipico Company Information
Table 53. Eipico Description and Business Overview
Table 54. Eipico Mebendazole Product
Table 55. Eipico Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Eipico Sales Proportion of Mebendazole by Product in 2024
Table 57. Eipico Sales Proportion of Mebendazole by Application in 2024
Table 58. Eipico Sales Proportion of Mebendazole by Geographic Area in 2024
Table 59. Eipico Recent Developments
Table 60. Esteve Pharmaceuticals Company Information
Table 61. Esteve Pharmaceuticals Description and Business Overview
Table 62. Esteve Pharmaceuticals Mebendazole Product
Table 63. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Esteve Pharmaceuticals Sales Proportion of Mebendazole by Product in 2024
Table 65. Esteve Pharmaceuticals Sales Proportion of Mebendazole by Application in 2024
Table 66. Esteve Pharmaceuticals Sales Proportion of Mebendazole by Geographic Area in 2024
Table 67. Esteve Pharmaceuticals Recent Developments
Table 68. Tenry Company Information
Table 69. Tenry Description and Business Overview
Table 70. Tenry Mebendazole Product
Table 71. Tenry Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Tenry Sales Proportion of Mebendazole by Product in 2024
Table 73. Tenry Sales Proportion of Mebendazole by Application in 2024
Table 74. Tenry Sales Proportion of Mebendazole by Geographic Area in 2024
Table 75. Tenry Recent Developments
Table 76. North America Mebendazole Sales by Country (2020-2025) & (K Units)
Table 77. North America Mebendazole Sales by Country (2026-2031) & (K Units)
Table 78. North America Mebendazole Revenue by Country (2020-2025) & (US$ Million)
Table 79. North America Mebendazole Revenue by Country (2026-2031) & (US$ Million)
Table 80. North America Mebendazole Sales by Type (2020-2025) & (K Units)
Table 81. North America Mebendazole Sales by Application (2020-2025) & (K Units)
Table 82. Asia-Pacific Mebendazole Sales by Region (2020-2025) & (K Units)
Table 83. Asia-Pacific Mebendazole Sales by Region (2026-2031) & (K Units)
Table 84. Asia-Pacific Mebendazole Revenue by Region (2020-2025) & (US$ Million)
Table 85. Asia-Pacific Mebendazole Revenue by Region (2026-2031) & (US$ Million)
Table 86. Asia-Pacific Mebendazole Sales by Type (2020-2025) & (K Units)
Table 87. Asia-Pacific Mebendazole Sales by Application (2020-2025) & (K Units)
Table 88. Europe Mebendazole Sales by Country (2020-2025) & (K Units)
Table 89. Europe Mebendazole Sales by Country (2026-2031) & (K Units)
Table 90. Europe Mebendazole Revenue by Country (2020-2025) & (US$ Million)
Table 91. Europe Mebendazole Revenue by Country (2026-2031) & (US$ Million)
Table 92. Europe Mebendazole Sales by Type (2020-2025) & (K Units)
Table 93. Europe Mebendazole Sales by Application (2020-2025) & (K Units)
Table 94. Latin America Mebendazole Sales by Country (2020-2025) & (K Units)
Table 95. Latin America Mebendazole Sales by Country (2026-2031) & (K Units)
Table 96. Latin America Mebendazole Revenue by Country (2020-2025) & (US$ Million)
Table 97. Latin America Mebendazole Revenue by Country (2026-2031) & (US$ Million)
Table 98. Latin America Mebendazole Sales by Type (2020-2025) & (K Units)
Table 99. Latin America Mebendazole Sales by Application (2020-2025) & (K Units)
Table 100. Middle East and Africa Mebendazole Sales by Country (2020-2025) & (K Units)
Table 101. Middle East and Africa Mebendazole Sales by Country (2026-2031) & (K Units)
Table 102. Middle East and Africa Mebendazole Revenue by Country (2020-2025) & (US$ Million)
Table 103. Middle East and Africa Mebendazole Revenue by Country (2026-2031) & (US$ Million)
Table 104. Middle East and Africa Mebendazole Sales by Type (2020-2025) & (K Units)
Table 105. Middle East and Africa Mebendazole Sales by Application (2020-2025) & (K Units)
Table 106. Mebendazole Key Raw Materials, Industry Status and Trend
Table 107. Mebendazole Key Raw Materials and Upstream Suppliers
Table 108. Mebendazole Clients Status and Trend
Table 109. Mebendazole Typical Clients
Table 110. Mebendazole Distributors
Table 111. Mebendazole Market Trends
Table 112. Mebendazole Market Drivers
Table 113. Mebendazole Market Challenges
Table 114. Mebendazole Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Mebendazole Product Picture
Figure 2. Global Mebendazole Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Mebendazole Sales Market Share by Type in 2024 & 2031
Figure 4. Tablet Product Picture
Figure 5. Oral Suspension Product Picture
Figure 6. Global Mebendazole Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Mebendazole Sales Market Share by Application in 2024 & 2031
Figure 8. Below 2 Years Old
Figure 9. Above 2 Years Old
Figure 10. Mebendazole Report Years Considered
Figure 11. Global Mebendazole Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Mebendazole Market Size 2020-2031 (US$ Million)
Figure 13. Global Mebendazole Sales 2020-2031 (K Units)
Figure 14. Global Mebendazole Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Mebendazole Revenue Market Share by Region (2020-2031)
Figure 16. Global Mebendazole Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Mebendazole Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Mebendazole Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 19. Global Mebendazole Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Mebendazole Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Mebendazole Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 22. Tablet of Mebendazole Revenue Market Share by Application, 2024 VS 2031
Figure 23. Oral Suspension of Mebendazole Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Mebendazole Sales Share by Manufacturer in 2024
Figure 25. Mebendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Tablet Market Sales Proportion by Manufacturer in 2024
Figure 27. Oral Suspension Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Mebendazole Revenue 2020-2031 (US$ Million)
Figure 29. North America Mebendazole Sales Market Share by Type (2020-2025)
Figure 30. North America Mebendazole Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Mebendazole Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Mebendazole Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Mebendazole Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Mebendazole Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Mebendazole Sales Market Share by Application (2020-2025)
Figure 36. Europe Mebendazole Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Mebendazole Sales Market Share by Country (2020-2031)
Figure 38. Europe Mebendazole Revenue Market Share by Country (2020-2031)
Figure 39. Europe Mebendazole Sales Market Share by Type (2020-2025)
Figure 40. Europe Mebendazole Sales Market Share by Application (2020-2025)
Figure 41. Latin America Mebendazole Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Mebendazole Sales Market Share by Country (2020-2031)
Figure 43. Latin America Mebendazole Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Mebendazole Sales Market Share by Type (2020-2025)
Figure 45. Latin America Mebendazole Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Mebendazole Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Mebendazole Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Mebendazole Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Mebendazole Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Mebendazole Sales Market Share by Application (2020-2025)
Figure 51. Mebendazole Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Mebendazole Raw Materials by Region in 2024
Figure 53. Mebendazole Distribution Channels
Figure 54. Global Mebendazole Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Mebendazole Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232